September 7, 2016
Swander Pace Capital Closes Oversubscribed Sixth Fund at $510 Million
Firm’s Largest Fund to Date Exceeds Initial Target of $400 Million.
July 19, 2016
Clarion Brands Makes Strategic Acquisition of Florajen®, the #1 Pharmacist-Recommended Probiotic
Clarion Brands, a portfolio company of Swander Pace Capital and a leading consumer product company specializing in over-the-counter (OTC) healthcare solutions, acquired Florajen®.
May 3, 2016
Swander Pace Capital Completes Sale of Renew Life Formulas, Inc. to Clorox Company
Swander Pace Capital has completed its sale of Renew Life Formulas, Inc., a global leader in probiotics and other digestive care supplements, to Clorox Company for $290 million.
December 14, 2015
Swander Pace Capital Acquires Captek Softgel International
Swander Pace Capital announced it has completed the acquisition of California-based Captek Softgel International (“Captek”).
September 17, 2015
Swander Pace Capital Sells Gilchrist & Soames, Inc. to Guest Supply, a Sysco Company
Swander Pace Capital sold Gilchrist & Soames, Inc. provider of premium bath and beauty products to luxury destinations throughout the world, to Guest Supply, a wholly owned subsidiary of Sysco Corp.
September 1, 2015
Swander Pace Capital-Backed Recochem, Inc. Acquires License for H2Blu from Wakefield, Inc.
Recochem Inc., a Swander Pace Capital portfolio company, has acquired the license for the H2Blu brand of diesel exhaust fluid (DEF) from Wakefield Inc.
July 21, 2015
Swander Pace Capital to Sell Merrick Pet Care to Nestlé Purina
Swander Pace Capital sold Merrick Pet Care (“Merrick”), a natural and organic pet food leader, to Nestlé Purina PetCare.
May 26, 2015
Swander Pace Capital Sells Investment in Applegate
Swander Pace Capital has sold its minority investment in Applegate, the nation’s leading natural and organic meat company, to Hormel Foods Corp in a transaction valued at $775 million.
November 10, 2014
Swander Pace Capital Forms Clarion Brands, Acquires Six Over-The-Counter Brands from DSE Healthcare Solutions
Swander Pace Capital has formed Clarion Brands Holding Corporation (Clarion), to acquire a portfolio of six niche over-the-counter (OTC) brands from DSE Healthcare Solutions, LLC.
September 3, 2014
Swander Pace Capital Finalizes Sale of Insight Pharmaceuticals for $750 Million
Swander Pace Capital finalized its sale of over-the-counter (OTC) products portfolio company Insight Pharmaceuticals (Insight) to Prestige Brands Holdings for $750 million.